GSK Plc (GSK)
48.12
0.00 (0.00%)
USD |
NYSE |
Sep 11, 16:00
48.12
0.00 (0.00%)
After-Hours: 16:29
GSK Gross Profit (TTM) : 32.65B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.65B |
| March 31, 2026 | 31.95B |
| December 31, 2025 | 31.27B |
| September 30, 2025 | 30.47B |
| June 30, 2025 | 29.35B |
| March 31, 2025 | 28.90B |
| December 31, 2024 | 28.74B |
| September 30, 2024 | 28.04B |
| June 30, 2024 | 28.10B |
| March 31, 2024 | 27.36B |
| December 31, 2023 | 26.61B |
| September 30, 2023 | 26.23B |
| June 30, 2023 | 25.16B |
| March 31, 2023 | 24.56B |
| December 31, 2022 | 24.47B |
| September 30, 2022 | 24.20B |
| June 30, 2022 | 24.25B |
| March 31, 2022 | 24.06B |
| December 31, 2021 | 24.88B |
| September 30, 2021 | 26.69B |
| June 30, 2021 | 27.92B |
| March 31, 2021 | 28.56B |
| December 31, 2020 | 29.61B |
| September 30, 2020 | 29.28B |
| June 30, 2020 | 29.33B |
| Date | Value |
|---|---|
| March 31, 2020 | 29.79B |
| December 31, 2019 | 28.75B |
| September 30, 2019 | 28.27B |
| June 30, 2019 | 27.68B |
| March 31, 2019 | 27.58B |
| December 31, 2018 | 27.44B |
| September 30, 2018 | 27.37B |
| June 30, 2018 | 27.05B |
| March 31, 2018 | 26.27B |
| December 31, 2017 | 25.59B |
| September 30, 2017 | 25.11B |
| June 30, 2017 | 24.88B |
| March 31, 2017 | 25.20B |
| December 31, 2016 | 25.04B |
| September 30, 2016 | 23.65B |
| June 30, 2016 | 23.32B |
| March 31, 2016 | 23.16B |
| December 31, 2015 | 22.94B |
| September 30, 2015 | 24.84B |
| June 30, 2015 | 25.05B |
| March 31, 2015 | 25.46B |
| December 31, 2014 | 26.30B |
| September 30, 2014 | 27.00B |
| June 30, 2014 | 27.56B |
| March 31, 2014 | 28.19B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| AstraZeneca PLC | 44.95B |
| Eli Lilly & Co. | 66.44B |
| Merck & Co., Inc. | 48.01B |
| Novartis AG | 40.59B |
| Pfizer Inc. | 41.30B |